Short Interest in Haoxi Health Technology Limited (NASDAQ:HAO) Declines By 24.7%

Haoxi Health Technology Limited (NASDAQ:HAO) saw a significant decline in short interest during the month of January. As of January 30th, there was short interest totaling 52,925 shares, a decline of 24.7% from the January 15th total of 70,304 shares. Currently, 0.6% of the shares of the company are sold short. Based on an average daily trading volume, of 27,107 shares, the short-interest ratio is presently 2.0 days. Based on an average daily trading volume, of 27,107 shares, the short-interest ratio is presently 2.0 days. Currently, 0.6% of the shares of the company are sold short.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Haoxi Health Technology in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

Haoxi Health Technology Price Performance

Haoxi Health Technology stock opened at $1.21 on Tuesday. Haoxi Health Technology has a 12-month low of $0.82 and a 12-month high of $2.31. The company has a current ratio of 5.05, a quick ratio of 5.05 and a debt-to-equity ratio of 0.02. The firm has a 50 day simple moving average of $1.24 and a 200-day simple moving average of $1.17.

Haoxi Health Technology Company Profile

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.